Skip to main content
. Author manuscript; available in PMC: 2022 Jul 18.
Published in final edited form as: Curr Med Res Opin. 2021 May 13;37(8):1303–1313. doi: 10.1080/03007995.2021.1920899

Table 2.

Baseline Characteristics of Older Adults with Dementia and OAB across Selective and Non-Selective Antimuscarinic Medications

Characteristics Selective Antimuscarinic
(n = 4,893; 22.40%)
Non-selective Antimuscarinic
(n = 16,955; 77.60%)
Standardized Difference of Proportions (D) P-value
Predisposing Characteristics
Age (in years) ≥ 65–75 years 1,434 (29.31) 4,853 (28.62) 0.02 0.31
≥ 75–85 years 2,231 (45.60) 7,669 (45.23)
≥ 85 years 1,228 (25.10) 4,433 (26.15)
Gender Male 1,760 (35.97) 5,320 (31.38) 0.10 <.0001*
Female 3,133 (64.03) 11,635 (68.62)
Race White 4,150 (84.82) 14,603 (86.13) 0.11 <.0001*
Black 286 (5.85) 1,212 (7.15)
Other 457 (9.34) 1,140 (6.72)
Need Characteristics
Abnormal Involuntary Movements 289 (5.91) 975 (5.75) −0.01 0.68
Anxiety 1,450 (29.63) 5,315 (31.35) 0.04 0.02*
Bipolar Disease 244 (4.99) 973 (5.74) 0.03 0.04*
Drug Induced Acute Dystonia 2 (0.04) 4 (0.02) −0.01 0.52
Gastro-esophageal Reflux Syndrome 1,869 (38.20) 6,349 (37.45) −0.02 0.34
Insomnia 862 (17.62) 2,829 (16.69) −0.02 0.13
Irritable Bowel Syndrome 209 (4.27) 632 (3.73) −0.03 0.08
Muscle Spasms/ Low Back Pain 1,597 (32.64) 5,009 (29.54) −0.07 <.0001*
Neuropathic Pain 137 (2.80) 461 (2.72) −0.00 0.76
Schizophrenia 133 (2.72) 612 (3.61) 0.05 0.00*
Secondary Parkinsonism 73 (1.49) 284 (1.68) 0.01 0.37
Benign Prostatic Hyperplasia 1,206 (68.52) 3,364 (63.23) −0.12 <.0001*
Chronic Constipation 1,221 (24.95) 4,419 (26.06) 0.03 0.12
Epilepsy 292 (5.97) 1,024 (6.04) 0.00 0.85
Delirium 913 (18.66) 3,606 (21.27) 0.07 <.0001*
Falls/Fractures 2,393 (48.91) 8,479 (50.01) 0.02 0.17
Myasthenia Gravis 15 (0.31) 52 (0.31) 0.00 0.99
Narrow-angle Glaucoma 850 (17.37) 2,743 (16.18) −0.03 0.05*
Parkinson’s Disease 556 (11.36) 1,850 (10.91) −0.01 0.37
Myocardial Infarction 185 (3.78) 725 (4.28) 0.03 0.13
Syncope 743 (15.18) 2,597 (15.32) 0.00 0.82
Urinary Tract Infection 2,704 (55.26) 9,602 (56.63) 0.03 0.09
Skin Infection 378 (7.73) 1,444 (8.52) 0.03 0.08
Vulvovaginitis 153 (3.13) 627 (3.70) 0.03 0.06
Baseline Anticholinergic Load 5,937 (35.02) 1,799 (36.77) −0.04 0.02*
Elixhauser’s Score (Mean, SD) 11.42 [10.48] 11.73 [10.64] 0.03 0.07

SD Standard Deviation,

*

Statistical significance at p-value < 0.05,

Denominator is male population within selective and non-selective antimuscarinic users